Using proprietary hydrogel technology and orthogonal analytics, Cypre has built a series of translatable 3D in vitro tumor models to discover and advance the next generation of therapeutics.
Cypre is a biotechnology company dedicated to working with therapeutic innovators to overcome drug resistance for cancer patients.
Used by top-10 pharmaceuticals, a multitude of biotechs, and leading academic centers, our 3D in vitro tumor microenvironment models allow our partners to rapidly screen and generate comprehensive insights into your therapeutic’s efficacy and mechanism of action.